Clinical Highlights from the 2020 Midyear: Finally, Maximizing Triglycerides Leads to Lower Cardiovascular Risk

In this episode featurette from the Section of Clinical Specialists and Scientists' presentation at the 2020 Midyear Clinical Meeting, Joel Marrs presents the definitions of hypertriglyceridemia based on the 2018 AHA/ACC Multisociety Guideline on the Management of Blood Cholesterol and help pharmacists identify risk factors for the development of hypertriglyceridemia.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.